antimicrobial resistance

News

GSK, UK govt put £130m into antimicrobial resistance fight

GSK has become the first founding partner of the new Fleming Initiative, which aims to tackle the rising threat of antimicrobial resistance (AMR) and is also backed by the

News

A close-up of a Mycobacterium tuberculosis culture

GSK commits to further support of BioVersys’ TB drug

GSK has expanded a collaboration with BioVersys on a new drug candidate for tuberculosis (TB) and contributed to an extension to the Swiss biotech’s third-round financing.

News

Top charities team up with $300m for climate, health equity

The Novo Nordisk Foundation, the Bill & Melinda Gates Foundation, and Wellcome have joined forces to tackle some of the most pressing threats to human health and wellb

R&D

AI and the battle against AMR

One of the largest threats facing public health is growing resistance to the world’s existing antibiotics.

News

GSK antibiotic gepotidacin clears phase 3 gonorrhoea trial

GSK has reported topline results from a phase 3 trial of its novel antibiotic gepotidacin that could spell the end of a decades-long drought in new oral therapies for gonorrhoea.

News

BARDA backs Locus phage therapy for resistant E coli

The US government has provided almost $24 million in funding to Locus Biosciences to support a mid-stage trial of LBP-EC01, a CRISPR-engineered bacteriophage therapy in de

GSK, UK govt put £130m into antimicrobial resistance fight

GSK commits to further support of BioVersys’ TB drug

Top charities team up with $300m for climate, health equity

AI and the battle against AMR

GSK antibiotic gepotidacin clears phase 3 gonorrhoea trial

BARDA backs Locus phage therapy for resistant E coli

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

antimicrobial resistance

Editor's Picks